Cargando…
Results of medium-term survival in patients undergoing cardiac transplantation: institutional experience
INTRODUCTION: The heart transplant became a consecrated therapy for patients with terminal heart failure, increasingly improving the survival. OBJECTIVE: To identify the medium-term results in patients undergoing cardiac transplantation. METHODS: This is a descriptive, documentary and retrospective...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cirurgia Cardiovascular
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389438/ https://www.ncbi.nlm.nih.gov/pubmed/24598951 http://dx.doi.org/10.5935/1678-9741.20130077 |
Sumario: | INTRODUCTION: The heart transplant became a consecrated therapy for patients with terminal heart failure, increasingly improving the survival. OBJECTIVE: To identify the medium-term results in patients undergoing cardiac transplantation. METHODS: This is a descriptive, documentary and retrospective study, using a quantitative approach, developed in a Unit of Transplant and Heart Failure, of a tertiary level public hospital, located in Fortaleza, CE, Brazil. The data were obtained from a sample of 188 patients (154 men and 34 women), submitted to the heart transplant, in the period from October 1997 to March 2011. There were calculated survival rates based on Kaplan-Meier methods. RESULTS: There were identified information about the patient's gender (male 81.91%), medical diagnosis which determined the heart transplantation (idiopathic cardiomyopathies 23.98%, ischemic 23.4% and Chagasic 17.02%). The median age of patients was 48 years old (interquartile range = 17.25 years) and the median observation period was 877 days. During this period, 78 patients died, resulting in survival ratios of 72%, 59% and 47% after 1, 5 and 9 years of cardiac transplantation, respectively. Younger patients had longer survival (P=0.0418). CONCLUSION: The medium-term survival of patients undergoing cardiac transplantation is significant, especially for younger patients. |
---|